Devices to Digital: Insights into the Medical Devices and eHealth Markets in Q1:23
The Medical Devices Market: As of May 26, 2023, a total of 46 Medical Device deals have been announced this year, and 28 of those deals were announced during Q1:23. The Q1:23 deal total is comparable to the 27 deals announced during Q1:22, yet an 18% drop from the 56 deals announced between January 1, 2022, and May 26, 2022. M&A activity is also 25% down compared to the 35 Medical Device deals announced during Q1:21, and 6% lower than the 49 deals announced between January 1, 2021, and May 26, 2021. While M&A is down compared to recent Q1’s, considering we just had a few years of unprecedented upheaval, the market is still at a better place than it was before the COVID-19 pandemic.... Read More »
Mixed Q1 2023 Results in the Diagnostics Sector: COVID-19 Testing Revenues Slump
The Diagnostics Market: Despite a bustling M&A market in 2022, the diagnostics sector appears to have experienced a slowdown in deal activity, though it still remains relatively strong compared with previous years. As of May 15, 2023, a total of 26 deals have been announced year-to-date. Although this represents a 42% decline compared to the 45 deals observed during the same period in 2022, it still signifies a substantial 44% and 86% increase from the deal count in 2021 and 2020, respectively. These figures highlight the enduring interest in the diagnostics market, which increased out of necessity during the COVID-19 pandemic and continues to drive investment and strategic... Read More »
April 2023 Healthcare M&A Market Update
According to recent data captured in the LevinPro HC database, the healthcare M&A market in April 2023 saw a total of 185 deals, an increase from the 169 deals in March 2023, yet a slight decrease from the 189 deals we saw in April 2022. The busiest sector in April 2023 was Physician Medical Groups (PMG), with 47 deals, followed by Other Services with 41 deals and eHealth with 24 deals. Private equity firms and their portfolio companies were responsible for acquiring 70 of the targets in April, making up 38% of all the deals announced during the month. One sector that saw a significant rise in deal totals was Medical Devices, with 12 deals announced in April 2023, compared to only... Read More »
HCA Healthcare Emerging from Severe Staffing Headwinds
HCA Healthcare Inc (NYSE: HCA), a for-profit healthcare provider based in Nashville, Tennessee, reported $4.93 earnings per share for the quarter, beating the consensus estimate of $3.99 by a whopping $0.94. This increase is largely due to HCA Healthcare’s revenue growth, which was up 4.3% on a year over year basis from $14.9 billion in Q1:22 to $15.6 billion in Q1:23. The healthcare provider’s expenses rose from the first quarter of 2022, reaching $13.67 billion. Yet, despite the rising expenses, HCA Healthcare reported a $1.36 billion profit in the first quarter, an improvement from last year’s profit of $1.27 billion. However, this is a decrease from HCA’s $2.1 billion... Read More »
UnitedHealth Group Revenues up 15%, Focus on Value-Based Care Pays Off
UnitedHealth Group Incorporated (NYSE: UNH), one of the largest health insurers in the United States, reported a positive performance in the first quarter of 2023, demonstrating balanced growth across its Optum and UnitedHealthcare business segments. The company’s revenue increased by 15% to $91.9 billion in Q1:23, and its adjusted earnings per share rose by 14% to $6.26 compared to the same period last year. Year-to-date, UnitedHealthcare also expanded its customer base, serving 1.2 million more people in the United States, with half of this growth coming from its commercial offerings. Additionally, the OptumHealth segment reported a significant increase in the number of patients... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
